Increasing the number of blood stem cells from umbilical cord blood

Expand human umbilical cord blood hematopoietic stem cells with PPAR-a agonists

NIH-funded research Coriell Institute for Medical Research · NIH-10954535

This study is looking at ways to increase the number of important blood stem cells from umbilical cord blood to make them more available for transplants, which can help people with blood-related illnesses.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionCoriell Institute for Medical Research NIH-funded
Lab location1 site (Camden, United States)
Project IDNIH-10954535 on NIH RePORTER

What this research studies

This research focuses on enhancing the quantity of hematopoietic stem cells (HSCs) derived from umbilical cord blood using specific compounds known as PPAR-a agonists. By expanding these stem cells, the research aims to improve their availability for transplants, which are crucial for treating blood-related diseases and disorders. The approach involves utilizing cryopreserved umbilical cord blood samples to develop new methods for increasing the number of functional HSCs, potentially leading to better patient outcomes in stem cell transplants.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals requiring hematopoietic stem cell transplants, particularly those with blood malignancies or hypoproliferative disorders.

Not a fit: Patients who do not require stem cell transplants or have conditions unrelated to blood disorders may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly improve the effectiveness and availability of stem cell transplants for patients with blood disorders.

How similar studies have performed: Previous studies have shown promise in expanding hematopoietic stem cells using various methods, indicating that this approach may build on established successes.

Where this research is happening

Camden, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Blood Diseases
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.